Loading…
Valencia Nutrition (BSE 542910)₹58.00−3.33%Other Beverages
In the Mar 2026 quarter (consolidated), Valencia Nutrition reported sales of ₹4.20 Cr, down 39.7% from Mar 2025, and net profit of ₹0.44 Cr, down 80.9% year on year. For the year to Mar 2026, sales were ₹7.91 Cr and net profit ₹1.10 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 1.56 | 6.96 | 3.70 | 4.20 |
| Expenses | 3.05 | 4.69 | 3.00 | 4.74 |
| Operating Profit | −1.50 | 2.26 | 0.71 | −0.55 |
| OPM % | −96.1% | 32.5% | 19.0% | −12.9% |
| Other Income | 0.34 | 0.33 | 0.36 | 1.36 |
| Interest | 0.04 | 0.07 | 0.06 | 0.05 |
| Depreciation | 0.00 | 0.19 | 0.31 | 0.31 |
| Profit before tax | −1.23 | 2.30 | 0.67 | 0.44 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | −1.23 | 2.30 | 0.67 | 0.44 |
| EPS (Rs) | −0.86 | 1.34 | 0.38 | 0.22 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 8.50 | 7.91 |
| Expenses | 7.72 | 7.74 |
| Operating Profit | 0.78 | 0.17 |
| OPM % | 9.1% | 2.0% |
| Other Income | 0.66 | 1.71 |
| Interest | 0.12 | 0.12 |
| Depreciation | 0.20 | 0.63 |
| Profit before tax | 1.09 | 1.10 |
| Tax % | 0.0% | 0.0% |
| Net Profit | 1.08 | 1.10 |
| EPS (Rs) | 0.62 | 0.58 |
| Dividend payout % | 0.0% | 0.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 16.94 | 18.30 |
| Reserves | 19.58 | 23.90 |
| Borrowings | 1.48 | 15.10 |
| Other Liabilities | 0.35 | 1.74 |
| Total Liabilities | 38.35 | 59.04 |
| Fixed Assets | 6.20 | 18.18 |
| CWIP | 0.00 | 8.42 |
| Investments | 2.92 | 1.74 |
| Other Assets | 29.23 | 30.70 |
| Inventories | 2.67 | 13.47 |
| Trade receivables | 6.47 | 8.45 |
| Cash & equivalents | 7.87 | 0.29 |
| Total Assets | 38.35 | 59.04 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from operating activity | −15.75 | −8.20 |
| Cash from investing activity | −10.15 | −16.75 |
| Cash from financing activity | 33.55 | 17.41 |
| Net cash flow | 7.65 | −7.57 |
| Capex | 4.07 | 20.34 |
| Free cash flow | −19.87 | −28.63 |
| CFO / OP % | −2,042.9% | −5,118.9% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor days | 280 | 393 |
| Inventory days | 216 | 1,577 |
| Days payable | 11 | 155 |
| Cash conversion cycle | 486 | 1,816 |
| Working capital days | 734 | 1,254 |
| ROCE % | — | 2.6% |
For the Mar 2026 quarter, Valencia Nutrition reported sales of ₹4.20 Cr, down 39.7% year on year and net profit of ₹0.44 Cr, down 80.9% year on year. The operating margin was −12.9%.
Valencia Nutrition's sales for the year to Mar 2026 were ₹7.91 Cr.
Net profit for the year to Mar 2026 was ₹1.10 Cr. Earnings per share over the same trailing period were ₹0.58.
Valencia Nutrition reported borrowings of ₹15.10 Cr at Mar 2026, against cash and equivalents of ₹0.29 Cr.
Cash from operations was −₹8.20 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹28.63 Cr.